Prevalence of the risk factors for QT prolongation and associated drug–drug interactions in a cohort of medical inpatients
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (1) , 109-115
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Drug-drug interactions contributing to QT prolongation in cardiac intensive care unitsJournal of Critical Care, 2013
- Prevalence and determinants of QT interval prolongation in medical inpatientsInternal Medicine Journal, 2011
- Prevention of Torsade de Pointes in Hospital SettingsJACC, 2010
- QT Interval Prolongation Associated with the Oral Use of Domperidone in an InfantPediatric Cardiology, 2005
- Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and womenJACC, 2004
- QT Prolongation with Antimicrobial AgentsDrugs, 2004
- Serious ventricular arrhythmias among users of cisapride and other QT‐prolonging agents in the United StatesPharmacoepidemiology and Drug Safety, 2002
- Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden deathJournal Of Hypertension, 1992
- QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.Circulation, 1991
- Prognostic value of prolonged ventricular repolarization following myocardial infarction: The BHAT experienceJournal of Clinical Epidemiology, 1990